[go: up one dir, main page]

PL3845215T3 - Doustne roztwory zawierające sole lisdeksamfetaminy - Google Patents

Doustne roztwory zawierające sole lisdeksamfetaminy

Info

Publication number
PL3845215T3
PL3845215T3 PL19386059.0T PL19386059T PL3845215T3 PL 3845215 T3 PL3845215 T3 PL 3845215T3 PL 19386059 T PL19386059 T PL 19386059T PL 3845215 T3 PL3845215 T3 PL 3845215T3
Authority
PL
Poland
Prior art keywords
lisdexamfetamine
salts
oral solutions
oral
solutions
Prior art date
Application number
PL19386059.0T
Other languages
English (en)
Inventor
Georgios Liolios
Ioannis Psarrakis
Original Assignee
Labomed Pharmaceutical Company S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69190593&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3845215(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Labomed Pharmaceutical Company S.A. filed Critical Labomed Pharmaceutical Company S.A.
Publication of PL3845215T3 publication Critical patent/PL3845215T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL19386059.0T 2019-12-30 2019-12-30 Doustne roztwory zawierające sole lisdeksamfetaminy PL3845215T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19386059.0A EP3845215B1 (en) 2019-12-30 2019-12-30 Oral solutions comprising lisdexamfetamine salts

Publications (1)

Publication Number Publication Date
PL3845215T3 true PL3845215T3 (pl) 2022-11-21

Family

ID=69190593

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19386059.0T PL3845215T3 (pl) 2019-12-30 2019-12-30 Doustne roztwory zawierające sole lisdeksamfetaminy

Country Status (17)

Country Link
US (3) US11576878B2 (pl)
EP (2) EP3845215B1 (pl)
AU (1) AU2020416052A1 (pl)
BR (1) BR112022012986A2 (pl)
CA (1) CA3165248A1 (pl)
CL (1) CL2022001792A1 (pl)
CO (1) CO2022010594A2 (pl)
DK (1) DK3845215T3 (pl)
ES (1) ES2929192T3 (pl)
HR (1) HRP20221241T1 (pl)
HU (1) HUE059869T2 (pl)
IL (1) IL294249B2 (pl)
LT (1) LT3845215T (pl)
MX (1) MX2022008191A (pl)
PL (1) PL3845215T3 (pl)
PT (1) PT3845215T (pl)
WO (1) WO2021136602A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250064759A1 (en) 2021-12-16 2025-02-27 Labomed Pharmaceutical Company S.A. Container comprising a lisdexamfetamine containing oral solution
BR102022009562A2 (pt) * 2022-05-17 2023-11-28 Ems.S.A. Composição líquida e seu uso, método de tratamento e kit
WO2024003797A1 (en) * 2022-06-30 2024-01-04 Ind-Swift Laboratories Limited Crystalline salts of lisdexamfetamine
EP4561528A1 (en) 2022-07-29 2025-06-04 Labomed Pharmaceutical Company S.A. Lisdexamfetamine containing oral solution
GR1010843B (el) * 2023-10-24 2025-01-09 Pharmaplot Private Compamy, Ποσιμο διαλυμα που περιλαμβανει λισδεξαμφεταμινη και διαδικασια παρασκευης αυτου

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105486B2 (en) 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7700561B2 (en) 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
WO2006121552A2 (en) 2005-04-08 2006-11-16 New River Pharmaceuticals Inc. Abuse-resistant amphetamine prodrugs
CA3144719A1 (en) * 2019-07-19 2021-01-28 Cheer Global Limited Hemoglobin-based therapeutic agents

Also Published As

Publication number Publication date
US11576878B2 (en) 2023-02-14
LT3845215T (lt) 2022-11-10
IL294249A (en) 2022-08-01
IL294249B1 (en) 2025-08-01
IL294249B2 (en) 2025-12-01
EP3845215A1 (en) 2021-07-07
DK3845215T3 (da) 2022-10-10
WO2021136602A1 (en) 2021-07-08
HRP20221241T1 (hr) 2022-12-09
US20230201142A1 (en) 2023-06-29
US20240390304A1 (en) 2024-11-28
US12433859B2 (en) 2025-10-07
BR112022012986A2 (pt) 2022-09-13
CA3165248A1 (en) 2021-07-08
US20210401781A1 (en) 2021-12-30
EP4098248A1 (en) 2022-12-07
HUE059869T2 (hu) 2023-01-28
CO2022010594A2 (es) 2022-08-19
AU2020416052A1 (en) 2022-07-14
EP3845215B1 (en) 2022-07-27
CL2022001792A1 (es) 2023-03-03
PT3845215T (pt) 2022-10-17
ES2929192T3 (es) 2022-11-25
MX2022008191A (es) 2022-08-02

Similar Documents

Publication Publication Date Title
IL294249B2 (en) Oral solutions containing lisdexamfetamine salts
CA195361S (en) Toothbrush
CA195311S (en) Toothbrush
CA207118S (en) Oral irrigator
CA193485S (en) Oral irrigator
CA207116S (en) Toothbrush
ZA202107474B (en) Sulcardine salts
CA196557S (en) Flosser
PL3834770T3 (pl) Wykałaczka wodna
SG11202110838RA (en) Cassette
PL3950365T3 (pl) Kaseta
CA193063S (en) Toothbrush
CA195883S (en) Toothbrush
PL3755373T3 (pl) Doustne roztwory zawierające tramadol
CA186940S (en) Toothbrush
CA186941S (en) Toothbrush
CA206245S (en) Toothbrush
CA196018S (en) Toothbrush
CA196017S (en) Toothbrush
CA196019S (en) Toothbrush
CA196627S (en) Interdental brush
CA196012S (en) Toothbrush
CA196011S (en) Toothbrush
GB202211269D0 (en) Salts
PH32019000495S1 (en) Toothbrush